SCHEMBL2940170

SCHEMBL2940170

Cc1ccccc1NC(=O)c1cnccc1CN1C(=O)N(c2ccc(S(=O)(=O)C(F)(F)F)cc2)C(=O)C1C

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 2/20 0.58
RXFP1 Q9HBX9 4/20 0.39
SMO Q99835 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.34
LMNA P02545 3/20 0.34
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
PKM P14618 1/20 0.34
PTGS1 P23219 1/20 0.34
PTGS2 P35354 1/20 0.34
NAMPT P43490 1/20 0.33
ALDH1A1 P00352 2/20 0.33
HPGD P15428 2/20 0.33
POLB P06746 1/20 0.33
TP53 P04637 1/20 0.33
KDM4E B2RXH2 1/20 0.33
MAPK1 P28482 1/20 0.33
HTT P42858 1/20 0.33
HSD17B10 Q99714 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2938505 0.90 IGF1R (0.61) IGF1RRXFP1SMONAMPTTP53
SCHEMBL2938933 0.87 IGF1R (0.60) IGF1RRXFP1SMONAMPT
SCHEMBL2940258 0.87 IGF1R (0.41) IGF1RSMOLMNANPC1RAB9A
SCHEMBL2938772 0.85 IGF1R (0.57) IGF1RRXFP1SMOSMN1; SMN2LMNA
SCHEMBL2941779 0.85 IGF1R (0.61) IGF1RRXFP1SMOSMN1; SMN2LMNA
SCHEMBL2937516 0.84 IGF1R (0.63) IGF1RRXFP1SMOSMN1; SMN2LMNA
SCHEMBL2936312 0.84 RXFP1 (0.39) IGF1RRXFP1LMNANPC1RAB9A
SCHEMBL2937464 0.84 IGF1R (0.62) IGF1RSMONAMPT
SCHEMBL2938663 0.83 IGF1R (0.58) IGF1RRXFP1NAMPT
SCHEMBL2937893 0.83 IGF1R (0.62) IGF1RRXFP1SMOPTGS1PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-B1 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA SA (FR) 2010-09-22 EP disclosed